The Chemours Company (NYSE:CC) Holdings Reduced by Folger Nolan Fleming Douglas Capital Management Inc.

Folger Nolan Fleming Douglas Capital Management Inc. lowered its stake in The Chemours Company (NYSE:CC - Free Report) by 5.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 679,826 shares of the specialty chemicals company's stock after selling 41,736 shares during the period. Chemours accounts for about 2.3% of Folger Nolan Fleming Douglas Capital Management Inc.'s holdings, making the stock its 7th largest holding. Folger Nolan Fleming Douglas Capital Management Inc. owned 0.46% of Chemours worth $21,442,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Fruth Investment Management raised its holdings in Chemours by 3.8% in the 4th quarter. Fruth Investment Management now owns 13,518 shares of the specialty chemicals company's stock worth $426,000 after purchasing an additional 500 shares during the period. Mariner LLC raised its holdings in Chemours by 1.8% in the 3rd quarter. Mariner LLC now owns 28,104 shares of the specialty chemicals company's stock worth $788,000 after purchasing an additional 503 shares during the period. Brown Advisory Inc. raised its holdings in Chemours by 3.4% during the third quarter. Brown Advisory Inc. now owns 15,801 shares of the specialty chemicals company's stock valued at $443,000 after acquiring an additional 514 shares during the period. Amalgamated Bank raised its holdings in Chemours by 0.5% during the third quarter. Amalgamated Bank now owns 97,665 shares of the specialty chemicals company's stock valued at $2,740,000 after acquiring an additional 526 shares during the period. Finally, IFP Advisors Inc raised its holdings in Chemours by 39.0% during the third quarter. IFP Advisors Inc now owns 2,232 shares of the specialty chemicals company's stock valued at $63,000 after acquiring an additional 626 shares during the period. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have commented on CC. Barclays decreased their price target on Chemours from $32.00 to $30.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 2nd. BMO Capital Markets raised Chemours from an "underperform" rating to an "outperform" rating and raised their price target for the company from $19.00 to $34.00 in a report on Tuesday, April 9th. Finally, UBS Group raised their price target on Chemours from $21.00 to $28.00 and gave the company a "neutral" rating in a report on Tuesday, April 2nd. Seven analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $30.89.

Chemours Price Performance

Shares of Chemours stock traded up $0.29 during trading on Friday, reaching $27.32. 776,635 shares of the stock traded hands, compared to its average volume of 1,222,749. The company has a market capitalization of $4.07 billion, a price-to-earnings ratio of -17.63 and a beta of 2.00. The Chemours Company has a 52-week low of $15.10 and a 52-week high of $39.05. The company has a debt-to-equity ratio of 5.40, a current ratio of 1.54 and a quick ratio of 1.00. The business has a fifty day simple moving average of $26.70 and a two-hundred day simple moving average of $27.82.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings results on Wednesday, March 27th. The specialty chemicals company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. The company had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.37 billion. Chemours had a positive return on equity of 51.73% and a negative net margin of 3.80%. Sell-side analysts expect that The Chemours Company will post 2.23 EPS for the current year.

Chemours Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a $0.25 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.00 annualized dividend and a yield of 3.66%. Chemours's dividend payout ratio is currently -64.52%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.